These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26493996)

  • 1. Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma.
    Huang CY; Batzorig U; Cheng WL; Huang MT; Chen W; Wei PL; Chang YJ
    Tumour Biol; 2016 Apr; 37(4):4295-304. PubMed ID: 26493996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma.
    Wei PL; Huang CY; Tai CJ; Batzorig U; Cheng WL; Hunag MT; Chang YJ
    Tumour Biol; 2016 Jun; 37(6):8219-27. PubMed ID: 26718209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
    Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D
    Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.
    Sui Y; Zheng X; Zhao D
    Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of tetrahydrobiopterin inhibits tumor angiogenesis in BALB/c-nu mice with hepatocellular carcinoma.
    Dai Y; Cui J; Gan P; Li W
    Oncol Rep; 2016 Aug; 36(2):669-75. PubMed ID: 27279530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment.
    Park SY; Lee YK; Kim HJ; Park OJ; Kim YM
    Oncol Rep; 2016 Mar; 35(3):1566-72. PubMed ID: 26707164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.
    Zhang Y; Huang W; Ran Y; Xiong Y; Zhong Z; Fan X; Wang Z; Ye Q
    Tumour Biol; 2015 Nov; 36(11):8309-16. PubMed ID: 26002580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.
    Baik SH; Lee J; Lee YS; Jang JY; Kim CW
    Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.
    Sui Z; Zhou J; Cheng Z; Lu P
    Tumour Biol; 2015 Aug; 36(8):6173-9. PubMed ID: 25787749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
    Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X
    Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
    Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
    Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo.
    Liang M; Liu J; Ji H; Chen M; Zhao Y; Li S; Zhang X; Li J
    Tumour Biol; 2015 Sep; 36(9):7085-91. PubMed ID: 25874498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma.
    Ribback S; Che L; Pilo MG; Cigliano A; Latte G; Pes GM; Porcu A; Pascale RM; Li L; Qiao Y; Dombrowski F; Chen X; Calvisi DF
    Cell Cycle; 2018; 17(12):1496-1512. PubMed ID: 29965794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.